Study of ammoxetine for depression
Treatments studied
Part of Mental health clinical trials.
This study tests a new medicine called ammoxetine for people with major depression. It aims to see if it can help reduce depressive symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with major depressive disorder (MDD) and are currently having a depressive episode.
- Your depression is moderate to severe, as measured by standard rating scales.
- You are not at high risk of suicide or self-harm.
- You have not had ineffective treatment with two or more antidepressants at full doses for at least 8 weeks each.
- You have not had certain treatments like electroconvulsive therapy (ECT) or psychotherapy in the past 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how a medication called memantine affects memory and mood in people with major depression who are not currently taking antidepressants. It involves MRI scans and may help find new ways to treat depression.
This study tests a new antidepressant tablet against an approved one to see which works better and is safer for adults with major depression. It may help find a more effective option for treating depressive symptoms.
This study tests a new combination of two medications (dextromethorphan and bupropion) as a treatment for major depressive disorder. It may be an option if you have not already tried many antidepressants that didn't work.
This study tests an investigational drug called KH607 for adults with major depressive disorder (MDD). It aims to see if the drug can reduce depression symptoms over time. Participants must stop other depression medications before starting and will be monitored closely.
This trial is for teenagers whose depression has not improved after trying one SSRI antidepressant. It compares switching to a different medication versus adding another medication to see which approach works better.
This trial tests an investigational medication for adults with major depressive disorder who are currently taking an antidepressant but still have symptoms. It aims to see if adding this new drug can improve mood better than a placebo.
Hear when a new Major Depressive Disorder (MDD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.